Abstract
Using the hypertransfused rat as a model, we have identified 2,3-dihydroxyhenzoic acid (2,3-DHB) as an orally effective iron-chelating agent. The iron excreted in response tc 2,3-DHB is excreted via the urine. The amount of iron excreted is a function of both the dose and time course of the drug administration. The chelation is specific for iron; there were no changes in the amounts of urinary calcium, magnesium, copper or zinc. The oral administration of 2,3-DHB decreased time absorption of iron (59FeCl3,) by the gut even when a physiological amount of iron was added. The LD5O of 2,3-DHB is greater than 3 g/kg in the rabbit. Rats and mice administered up to 600 mg/kg chronically have shown no signs of toxicity.
Footnotes
- Received March 8, 1974.
- Accepted May 13, 1974.
- © 1974 by The Williams & Wilkins Co.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.